Wednesday May 28, 7:50 am ET
SAN FRANCISCO--(BUSINESS WIRE)--Osteologix, Inc. (OTC BB: OLGX.OB) today announced that Philip J. Young, President and CEO of Osteologix, will present a corporate overview on Thursday, May 29, at 9:00 a.m. ET during the FBR Capital Markets 12th Annual Spring Investor Conference at The Grand Hyatt New York Hotel in New York City. A live audio webcast and slide presentation will be available via the internet by visiting www.osteologix.com and clicking the link provided under ?Latest News?. An archived presentation will be available for 90 days.
About Osteologix
Osteologix is a specialty biopharmaceutical company committed to improving the health of those afflicted with musculoskeletal diseases, such as osteoporosis, by developing innovative therapies. Its lead investigational product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. For more information please visit www.osteologix.com.
For Further Information, Contact:
RedChip Companies, Inc.
500 Winderley Place, Suite 100, Maitland, FL 32751,
(800) 733-2447,Fax: (407) 644-0758,
info@redchip.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment